D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, and SOFIE Biosciences (SOFIE), a ...

The approval of anti-amyloid therapies has ... positron emission tomography (PET), cerebrospinal fluid (CSF) biomarkers and structural magnetic resonance imaging. AD pathology can be indexed ...

The relationship between amyloid β (Aβ) deposition and cognitive ... If PiB retention is indeed a predictor of Alzheimer disease, PiB PET might provide an early indication of risk—years ...

PET imaging uses a radioactive drug (tracer ... identified a radiotracer that could be used to detect the presence of amyloid protein plaques in the brain, which are among the markers for ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...